Home/Filings/4/0001209191-18-025826
4//SEC Filing

Atlas Venture Associates IX, L.P. 4

Accession 0001209191-18-025826

CIK 0001718108other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 4:18 PM ET

Size

12.9 KB

Accession

0001209191-18-025826

Insider Transaction Report

Form 4
Period: 2018-04-23
Transactions
  • Conversion

    Common Stock

    2018-04-23+3,181,8174,545,453 total
  • Purchase

    Common Stock

    2018-04-23$15.00/sh+100,000$1,500,0004,645,453 total
  • Conversion

    Series A Preferred Stock

    2018-04-237,000,0000 total
    Common Stock (3,181,817 underlying)
Transactions
  • Conversion

    Series A Preferred Stock

    2018-04-237,000,0000 total
    Common Stock (3,181,817 underlying)
  • Purchase

    Common Stock

    2018-04-23$15.00/sh+100,000$1,500,0004,645,453 total
  • Conversion

    Common Stock

    2018-04-23+3,181,8174,545,453 total
Transactions
  • Purchase

    Common Stock

    2018-04-23$15.00/sh+100,000$1,500,0004,645,453 total
  • Conversion

    Series A Preferred Stock

    2018-04-237,000,0000 total
    Common Stock (3,181,817 underlying)
  • Conversion

    Common Stock

    2018-04-23+3,181,8174,545,453 total
Footnotes (2)
  • [F1]The Series A Preferred Stock automatically converted into the Issuer's common stock on a 2.2-for-1 basis at the closing of the Issuer's initial public offering without payment or further consideration and had no expiration date.
  • [F2]The shares are held directly by Atlas Venture Fund IX, L.P. ("Atlas Venture Fund IX"). The general partner of Atlas Venture Fund IX is Atlas Venture Associates IX, L.P. ("AVA IX LP"). Atlas Venture Associates IX, LLC ("AVA IX LLC") is the general partner of AVA IX LP. Each of AVA IX LP and AVA IX LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund IX, except to the extent of its pecuniary interest therein, if any.

Issuer

Surface Oncology, Inc.

CIK 0001718108

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001671208

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 4:18 PM ET
Size
12.9 KB